Pharmacokinetic evaluation of doxorubicin plasma levels in normal and overweight patients with breast cancer and simulation of dose adjustment by different indexes of body mass
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference18 articles.
1. Role of body surface area in dosing of investigational anticancer agents in adults, 1991–2001;Baker;J. Natl. Cancer Inst.,2002
2. Overweight as an avoidable cause of cancer in Europe;Bergstrom;Int. J. Cancer,2001
3. Anthracycline antibiotics in cancer therapy: focus on drug resistance;Booser;Drugs,1994
4. Determination of doxorubicin and doxorubicinol in plasma of cancer patients by high-performance liquid chromatography;Bruijn;Anal. Biochem.,1999
5. Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer;Budman;J. Natl. Cancer Inst.,1998
Cited by 113 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Microdialysis as a sampling tool for the chemotherapeutic agent Doxorubicin;Journal of Pharmaceutical and Biomedical Analysis;2024-02
2. Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update;Journal of Chromatography B;2024-02
3. Harnessing physical activity monitoring and digital biomarkers of frailty from pendant based wearables to predict chemotherapy resilience in veterans with cancer;Scientific Reports;2024-01-31
4. 14,15-Dihydroxyeicosatrienoic acid, a soluble epoxide hydrolase metabolite in blood, is a predictor of anthracycline-induced cardiotoxicity – a hypothesis generating study;Cardio-Oncology;2023-12-15
5. Dexrazoxane does not mitigate early vascular toxicity induced by doxorubicin in mice;PLOS ONE;2023-11-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3